ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Rocket Pharmaceuticals Announces Presentations at the American College of Cardiology 2019 Annual Meeting
March 18, 2019"RP-A501 is the first investigational gene therapy for Danon disease and has the potential to revolutionize the treatment of this devastating cardiomyopathy. We are excited to move RP-A501 into the clinic in the second quarter of 2019," concluded Dr. Schw
Pharma Sources Insight January 2025
